Detection of a DNA Methylation Signature for the Intellectual Developmental Disorder, X-Linked, Syndromic, Armfield Type

Int J Mol Sci. 2021 Jan 23;22(3):1111. doi: 10.3390/ijms22031111.

Abstract

A growing number of genetic neurodevelopmental disorders are known to be associated with unique genomic DNA methylation patterns, called episignatures, which are detectable in peripheral blood. The intellectual developmental disorder, X-linked, syndromic, Armfield type (MRXSA) is caused by missense variants in FAM50A. Functional studies revealed the pathogenesis to be a spliceosomopathy that is characterized by atypical mRNA processing during development. In this study, we assessed the peripheral blood specimens in a cohort of individuals with MRXSA and detected a unique and highly specific DNA methylation episignature associated with this disorder. We used this episignature to construct a support vector machine model capable of sensitive and specific identification of individuals with pathogenic variants in FAM50A. This study contributes to the expanding number of genetic neurodevelopmental disorders with defined DNA methylation episignatures, provides an additional understanding of the associated molecular mechanisms, and further enhances our ability to diagnose patients with rare disorders.

Keywords: Armfield X-linked intellectual disability; DNA methylation; FAM50A; constitutional disorders; epigenetics; episignature.

MeSH terms

  • Adult
  • Case-Control Studies
  • Child
  • DNA Methylation*
  • DNA-Binding Proteins / genetics
  • Epigenome
  • Humans
  • Male
  • Mental Retardation, X-Linked / etiology
  • Mental Retardation, X-Linked / genetics*
  • Middle Aged
  • Models, Genetic
  • Neurodevelopmental Disorders / genetics
  • RNA-Binding Proteins / genetics

Substances

  • DNA-Binding Proteins
  • FAM50A protein, human
  • RNA-Binding Proteins

Supplementary concepts

  • Armfield X-Linked Mental Retardation Syndrome